Total Payments
$69,343
2024 Payments
$15,634
Companies
35
Transactions
350
Medicare Patients
12,243
Medicare Billing
$11.6M
Payment Breakdown by Category
Consulting$47,210 (68.1%)
Food & Beverage$15,207 (21.9%)
Other$5,453 (7.9%)
Travel$1,473 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $47,210 | 22 | 68.1% |
| Food and Beverage | $15,207 | 318 | 21.9% |
| Honoraria | $5,453 | 5 | 7.9% |
| Travel and Lodging | $1,473 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $17,463 | 77 | $0 (2024) |
| Genentech USA, Inc. | $14,406 | 75 | $0 (2024) |
| Alcon Vision LLC | $8,264 | 23 | $0 (2023) |
| Alimera Sciences, Inc. | $6,850 | 28 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $5,783 | 6 | $0 (2023) |
| Carl Zeiss Meditec, Inc. | $4,022 | 2 | $0 (2019) |
| Ocular Therapeutix, Inc. | $2,343 | 3 | $0 (2023) |
| Alcon Research LLC | $2,100 | 3 | $0 (2023) |
| Genentech, Inc. | $1,882 | 2 | $0 (2022) |
| Optos, Inc. | $1,049 | 8 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,634 | 67 | Regeneron Healthcare Solutions, Inc. ($9,946) |
| 2023 | $14,532 | 58 | Regeneron Healthcare Solutions, Inc. ($5,853) |
| 2022 | $13,340 | 57 | Alcon Vision LLC ($7,074) |
| 2021 | $6,997 | 30 | Regeneron Pharmaceuticals, Inc. ($5,400) |
| 2020 | $1,092 | 18 | Alcon Vision LLC ($434.79) |
| 2019 | $11,917 | 47 | Genentech USA, Inc. ($5,186) |
| 2018 | $1,410 | 37 | Genentech USA, Inc. ($414.34) |
| 2017 | $4,422 | 36 | Genentech USA, Inc. ($3,774) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: OPTOMETRY | ||||||
| 12/09/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: EYE CARE | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $2.91 | General |
| Category: Ophthalmology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/12/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Notal Vision, Inc. | Foresee Home (Device) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Ophthalmology | ||||||
| 11/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $102.67 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: EYE CARE | ||||||
| 10/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $69.30 | General |
| Category: EYE CARE | ||||||
| 09/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $26.64 | General |
| Category: Ophthalmology | ||||||
| 09/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.07 | General |
| Category: EYE CARE | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Ophthalmology | ||||||
| 09/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Consulting Fee | Cash or cash equivalent | $940.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/05/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $107.60 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/04/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $29.63 | General |
| 09/03/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Ophthalmology | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/21/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/19/2024 | Alimera Sciences, Inc. | ILUVIEN (Drug), YUTIQ | Honoraria | Cash or cash equivalent | $1,850.00 | General |
| Category: treatment of diabetic macular edema in patients who have been previously treated with corticosteroid | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,566 | 21,292 | $4.9M | $2.5M |
| 2022 | 22 | 2,707 | 12,529 | $5.6M | $2.8M |
| 2021 | 21 | 3,324 | 12,362 | $6.4M | $3.3M |
| 2020 | 24 | 3,646 | 12,046 | $5.7M | $3.0M |
Total Patients
12,243
Total Services
58,229
Medicare Billing
$11.6M
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 210 | 1,990 | $2.5M | $1.4M | 55.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 47 | 12,480 | $622,500 | $362,190 | 58.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 39 | 730 | $365,000 | $134,536 | 36.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 326 | 1,301 | $334,462 | $115,276 | 34.5% |
| J3490 | Unclassified drugs | Office | 2023 | 29 | 54 | $130,060 | $88,762 | 68.2% |
| 92134 | Imaging of retina | Office | 2023 | 716 | 2,208 | $164,055 | $60,128 | 36.7% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 23 | 481 | $79,365 | $57,893 | 72.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 312 | 609 | $145,482 | $56,201 | 38.6% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 24 | 294 | $84,011 | $46,431 | 55.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 388 | 607 | $102,270 | $35,713 | 34.9% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 37 | 44 | $72,815 | $27,879 | 38.3% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 35 | 35 | $70,277 | $27,215 | 38.7% |
| J3590 | Unclassified biologics | Office | 2023 | 23 | 70 | $41,500 | $23,308 | 56.2% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 19 | 19 | $38,495 | $15,471 | 40.2% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 13 | 14 | $34,350 | $12,390 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $32,459 | $11,906 | 36.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 12 | 14 | $30,625 | $10,813 | 35.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $20,331 | $7,035 | 34.6% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 13 | 14 | $8,766 | $3,157 | 36.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 16 | 17 | $7,504 | $2,634 | 35.1% |
| 92250 | Photography of the retina | Office | 2023 | 51 | 73 | $5,002 | $1,958 | 39.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 11 | 11 | $2,696 | $896.23 | 33.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 21 | 26 | $2,307 | $824.02 | 35.7% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 271 | 2,446 | $3.1M | $1.7M | 57.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 106 | 2,245 | $1.1M | $505,008 | 45.0% |
About Dr. Thomas Stone, M.D
Dr. Thomas Stone, M.D is a Ophthalmology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528064219.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Stone, M.D has received a total of $69,343 in payments from pharmaceutical and medical device companies, with $15,634 received in 2024. These payments were reported across 350 transactions from 35 companies. The most common payment nature is "Consulting Fee" ($47,210).
As a Medicare-enrolled provider, Stone has provided services to 12,243 Medicare beneficiaries, totaling 58,229 services with total Medicare billing of $11.6M. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Louisville, KY
- Active Since 06/27/2005
- Last Updated 07/12/2023
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1528064219
Products in Payments
- EYLEA (Biological) $15,502
- Lucentis (Biological) $11,318
- EYLEA HD (Biological) $7,103
- Constellation (Device) $4,943
- ILUVIEN (Drug) $4,703
- Vabysmo (Drug) $4,426
- Clarus 700 (Device) $4,000
- Iluvien (Drug) $1,219
- YUTIQ (Drug) $1,157
- Syfovre (Drug) $739.57
- PANORAMIC OPHTHALMOSCOPE (Device) $679.31
- EYLEA AFLIBERCEPT INJECTION (Biological) $641.07
- NGENUITY (Device) $576.70
- OZURDEX (Drug) $538.24
- DAILIES (Device) $309.67
- ACTHAR (Biological) $253.18
- VABYSMO (Drug) $241.19
- Rhopressa (Drug) $236.55
- LenSx (Device) $223.18
- BEOVU (Drug) $216.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Louisville
Dr. Brennan Greene, Md, MD
Ophthalmology — Payments: $154,528
Ophthalmology $154,528
Guruprasad Pattar, M.d, M.D
Ophthalmology — Payments: $93,365
Ophthalmology $93,365
Dr. George John, Md, MD
Ophthalmology — Payments: $30,207
Ophthalmology $30,207
Dr. Richard Eiferman, Md, MD
Ophthalmology — Payments: $14,887
Ophthalmology $14,887
Christopher Compton, M.d, M.D
Ophthalmology — Payments: $13,482
Ophthalmology $13,482
Dr. John Meyer, Md, MD
Ophthalmology — Payments: $12,061
Ophthalmology $12,061